Page breadcrumb nav

VAERS Report 2156846

Case Report Section

Vaer Report Details

Age: NA

Gender: Male

State: Outside US

Patient Died?
Vaccine information


Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: unknown

Date report was received
Date form completed
Date Vaccinated
Date of Onset
Number of days (onset date – vaccination date)
Adverse Event Description

phlegm; flu-like symptoms; very raw nasal cavity; cold symptoms; sore throat; sore eyes; earache; muscle ache; primary immunisation: non-pfizer vaccine; booster: comirnaty; primary immunisation: non-pfizer vaccine; booster: comirnaty; sneezing; headache; thick mucus in throat; all over body ache; this is a spontaneous report from a contactable consumer, the patient. this is a report received from the regulatory agency (ra). regulatory authority report number is gb-mhra-webcovid-202202191747011040-xsaxh with safety report unique identifier gb-mhra-adr 26625912. a 45-year-old male patient received third (booster) dose of bnt162b2 (comirnaty; lot number: unknown) via an unspecified route of administration on 13feb2022 as a single dose for covid-19 immunisation. medical history was not reported. it was reported that the patient was not taking medicines. on 26jan2022, the patient underwent covid-19 virus test and the result was negative. the patient did not have symptoms associated with covid-19 and was not enrolled in clinical trial. concomitant medications were not reported. the patient previously received first and second dose of covid-19 vaccine (manufacturer unknown); both on unknown dates, for covid-19 immunisation. on 13feb2022 the patient experienced primary immunisation: non-pfizer vaccine; booster: comirnaty.on 14feb2022, 1 day after vaccination, the patient experienced cold symptoms, sore throat, sore eyes, earache, muscle ache; on 15feb2022, 2 days after vaccination, the patient experienced phlegm; on an unknown date in feb2022, the patient experienced sneezing, headache; all the events were reported as serious for being medically significant. the clinical course reported as follows: on 14feb2022, within one day the patient experienced flu-like symptoms, these started with sore eyes, sore throat and sore ears with very raw nasal cavity and headache. these lasted about 2 days and have now left sneezing, thick mucus in throat (medically significant ) and on an unknown date in feb2022, the patient experienced all over body ache. the clinical outcome of the events sore eyes was recovered on 15feb2022 after the duration of 1 day, while that of sore throat, earache was recovered on 16feb2022 after the duration of 2 days. the clinical outcome of the events sneezing, cold symptoms, headache and very raw nasal cavity was recovered on an unknown date in feb2022. the clinical outcome of the events muscle ache and phlegm was not recovered, while that of the events all over body ache, flu-like symptoms, thick mucus in throat, primary immunisation: non-pfizer vaccine; booster: comirnaty were unknown. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Lab Data
test date: 20220126; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
List of symptoms
headache pain productive cough ear pain eye pain myalgia influenza like illness interchange of vaccine products nasal discomfort oropharyngeal pain nasopharyngitis sars-cov-2 test sneezing off label use increased viscosity of bronchial secretion
Patient Died?
Date Died
Birth defect
Vaccine Administered By:
Vaccine Purchased By:
Patient visit ER?
Patient Hospitalized?
Stay in hospital
Days in hospital
Permanent disability?
Current Illness